Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
Analysis of the efficacy and the compatibility of deep regional hyperthermia in combination with radiotherapy and chemoradiotherapy in bladder cancer
Trial Details
- NCT ID
- NCT05397262
- Phase
- NA
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Status
- RECRUITING
- Cancer Type
- Bladder Cancer
- Interventions
- Hyperthermia
- Radiotherapy
- Chemotherapy 5-Fluorouracil
- Chemotherapy Cisplatin
- Locations (sample)
- Erlangen, Germany|49.59099,11.00783
Key Eligibility Criteria
- Age ≥ 18 years
- Histologically confirmed bladder cancer
- ECOG-performance status ≤ 2
- Informed consent
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Bladder Cancer Trials on Trialify →